Enovis Free Cash Flow 2010-2024 | ENOV
Enovis Annual Free Cash Flow | |
---|---|
2023 | 45.34 |
2022 | -158.57 |
2021 | 258.90 |
2020 | 196.70 |
2019 | 13.33 |
2018 | 191.55 |
2017 | 171.23 |
2016 | 190.97 |
2015 | 233.94 |
2014 | 301.30 |
2013 | 290.69 |
2012 | 90.83 |
2011 | 43.53 |
2010 | 49.51 |
2009 | 27.92 |
Enovis Quarterly Free Cash Flow | |
---|---|
2024-03-31 | -73.08 |
2023-12-31 | 45.34 |
2023-09-30 | 14.87 |
2023-06-30 | -31.69 |
2023-03-31 | -22.99 |
2022-12-31 | -158.57 |
2022-09-30 | -85.83 |
2022-06-30 | -84.36 |
2022-03-31 | -35.77 |
2021-12-31 | 258.90 |
2021-09-30 | 189.20 |
2021-06-30 | 121.30 |
2021-03-31 | 59.85 |
2020-12-31 | 196.70 |
2020-09-30 | 96.48 |
2020-06-30 | 47.78 |
2020-03-31 | 26.80 |
2019-12-31 | 13.33 |
2019-09-30 | -27.16 |
2019-06-30 | -50.27 |
2019-03-31 | -95.36 |
2018-12-31 | 191.55 |
2018-09-30 | 78.32 |
2018-06-30 | 23.49 |
2018-03-31 | -4.72 |
2017-12-31 | 171.23 |
2017-09-30 | 94.04 |
2017-06-30 | 71.80 |
2017-03-31 | 28.70 |
2016-12-31 | 190.97 |
2016-09-30 | 60.18 |
2016-06-30 | 30.92 |
2016-03-31 | 0.13 |
2015-12-31 | 233.94 |
2015-09-30 | 119.41 |
2015-06-30 | 48.55 |
2015-03-31 | -13.21 |
2014-12-31 | 301.30 |
2014-09-30 | 142.47 |
2014-06-30 | -5.14 |
2014-03-31 | -79.63 |
2013-12-31 | 290.69 |
2013-09-30 | 135.93 |
2013-06-30 | 50.04 |
2013-03-31 | -31.39 |
2012-12-31 | 90.83 |
2012-09-30 | -49.30 |
2012-06-30 | -72.06 |
2012-03-31 | -128.18 |
2011-12-31 | 43.53 |
2011-09-30 | 30.96 |
2011-06-30 | 22.04 |
2011-03-31 | 1.68 |
2010-12-31 | 49.51 |
2010-09-30 | 26.02 |
2010-06-30 | 22.01 |
2010-03-31 | 13.60 |
2009-12-31 | 27.92 |
2009-09-30 | 26.46 |
2009-06-30 | 12.12 |
2009-03-31 | 7.58 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $2.875B | $1.707B |
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $37.366B | 20.52 |
Inspire Medical Systems (INSP) | United States | $4.612B | 0.00 |
Axonics (AXNX) | United States | $3.446B | 0.00 |
Hims & Hers Health (HIMS) | United States | $3.129B | 0.00 |
10x Genomics (TXG) | United States | $2.980B | 0.00 |
Olink Holding AB (publ) (OLK) | Sweden | $2.978B | 0.00 |
IRhythm Technologies (IRTC) | United States | $2.950B | 0.00 |
Azenta (AZTA) | United States | $2.743B | 154.15 |
Privia Health (PRVA) | United States | $2.016B | 112.67 |
Schrodinger (SDGR) | United States | $1.654B | 0.00 |
Omnicell (OMCL) | United States | $1.398B | 48.32 |
Phreesia (PHR) | United States | $1.393B | 0.00 |
Standard BioTools (LAB) | United States | $0.746B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.662B | 0.00 |
Definitive Healthcare (DH) | United States | $0.649B | 0.00 |
Talkspace (TALK) | United States | $0.467B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.442B | 0.00 |
Health Catalyst (HCAT) | United States | $0.410B | 0.00 |
Pulmonx (LUNG) | United States | $0.349B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.296B | 0.00 |
Butterfly Network (BFLY) | United States | $0.217B | 0.00 |
P3 Health Partners (PIII) | United States | $0.191B | 0.00 |
Outset Medical (OM) | United States | $0.187B | 0.00 |
American Well (AMWL) | United States | $0.145B | 0.00 |
TruBridge (TBRG) | United States | $0.134B | 7.19 |
111 (YI) | China | $0.111B | 0.00 |
MSP Recovery (LIFW) | United States | $0.107B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.075B | 0.00 |
Future Health ESG (FHLT) | United States | $0.070B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.064B | 0.00 |
Augmedix (AUGX) | United States | $0.059B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.057B | 0.00 |
HeartBeam (BEAT) | United States | $0.055B | 0.00 |
Zepp Health (ZEPP) | China | $0.054B | 0.00 |
CareCloud (CCLD) | United States | $0.045B | 0.00 |
Movano (MOVE) | United States | $0.042B | 0.00 |
Akili (AKLI) | United States | $0.034B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.031B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.022B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
Cue Health (HLTH) | United States | $0.015B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
Syra Health (SYRA) | United States | $0.010B | 0.00 |
Biotricity (BTCY) | United States | $0.010B | 0.00 |
Transgenomic (PRPO) | United States | $0.009B | 0.00 |
Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
HeartSciences (HSCS) | United States | $0.005B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
Centogene (CNTG) | Germany | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |